Evidence map›Paper›PMID 30937314›Full record

ArticleJournal of diabetes research2019

A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human

Jide Tian, Hoa Dang, Nataliya Karashchuk, Irvin Xu, Daniel L Kaufman

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. The role of GABA in type 1 diabetes.Frontiers in endocrinology · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. The Dual Role of the GABAInternational journal of molecular sciences · 2021
    Article
  7. GABABiomedicines · 2021
    Article
  8. Article
  9. Article
  10. Paracrine signaling in islet function and survival.Journal of molecular medicine (Berlin, Germany) · 2020
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jide TianDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.ORCID 0000-0002-5127-0970
Hoa DangDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
Nataliya KarashchukDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
Irvin XuDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
Daniel L KaufmanDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.ORCID 0000-0002-9844-5918
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A major goal of T1D research is to develop new approaches to increase

Indexed as

Cell SurvivalInflammationAlprazolamAnimalsApoptosisCell DivisionCell Proliferationgamma-Aminobutyric AcidHumansInsulin-Secreting CellsIslets of LangerhansMiceMice, Inbred C57BLMice, Inbred NODMice, SCIDMuramidaseAlprazolamgamma-Aminobutyric AcidMuramidaseReceptors, GABA

Identifiers

PMID30937314
PMCPMC6413367
OpenAlexW2915433992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.